BRS5(FM2) - Microbial Metabolite Signalling Capacity
(Gut Bacteria Signals That Reach the Body)
1. Definition
A functional control point governing production of beneficial microbial metabolites that shape immune, endocrine, and neurobiological signalling.
- Drives microbial ecological turnover and competitive selection of beneficial functions.
- Produces short-chain fatty acids that influence barrier, inflammation, and brain signalling.
- Biotransforms polyphenols into mitochondrial-relevant metabolites such as urolithin A — Supporting BRS4.
2. Primary Biological Effects
↑ SCFA signalling; ↑ polyphenol biotransformation; ↑ metabolite-mediated gut-brain communication
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Microbial ecological turnover and SCFA production jointly generate metabolite signals that can support attention-relevant gut–brain communication when fermentable substrate patterns are adequate. Human microbiome disruption and SCFA-signalling reviews support low–medium biological relevance without claiming fibre or metabolite interventions treat ADHD.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low
- Synthesis: Ecological substrate processing and polyphenol biotransformation generate microbial metabolites that can support mitochondrial-relevant signalling context for cognitive clarity. Current ADHD-linked evidence remains largely associative, so confidence stays low pending stronger mechanism–phenome bridging.
- Key References:
- Evidence Confidence: Low
- Biology → Phenome Confidence: Low
- Synthesis: SCFA signalling contributes to gut–brain metabolite tone that may indirectly influence emotional regulation pathways. Attached evidence is limited and translational, so Biology → Phenome and Evidence Confidence remain low at this integrated FM level.
- Key References:
- Evidence Confidence: Low
4. Mechanistic Basis (Integrated FM Narrative)
Microbial metabolite signalling capacity emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.
4.1 Core Primary Mechanisms
-
BRS5-FM2-PM4 — Microbial Ecological Turnover & Competitive Selection Continuous renewal of the gut microbial ecosystem driven by substrate availability and ecological competition, leading to selection of taxa and functions over time.
-
BRS5-FM2-PM5 — SCFA Production & Signalling Microbial fermentation of fibres into short-chain fatty acids that influence barrier function, inflammation, metabolism, and brain signalling.
-
BRS5-FM2-PM6 — Polyphenol Biotransformation & Mitochondrial-Relevant Metabolite Generation Microbial conversion of dietary polyphenols into downstream metabolites such as urolithin A that influence mitochondrial and inflammatory resilience.
4.2 Integrated Functional Narrative
Together, these PMs operationalise BRS5(FM2) as coordinated microbial metabolite signalling capacity.
At the integrated FM level, this is the main mechanism set through which plant diversity, fermentable fibres, and microbiome-active polyphenols are translated into downstream physiological effects, rather than remaining as unprocessed dietary inputs [Wastyk et al., 2021; Andreux et al., 2019; Singh et al., 2022].
4.3 Suboptimal Function & Its Effects
Microbial metabolite signalling capacity may weaken when fermentable fibre availability, or polyphenol & plant-diversity input availability become inadequate, or when supporting biological pools are chronically strained.
Low fibre and low plant-diversity dietary patterns may reduce BRS5(KC1) — Fermentable Fibre Availability. Ultra-processed diets displacing fermentable whole-food substrates may further strain pool availability, repeated low-intake of resistant starch and soluble fibre classes, erratic meal patterns reducing consistent microbial substrate delivery, while inflammatory or metabolic burden increasing ecological instability.
Low plant diversity over time may reduce BRS5(KC2) — Polyphenol & Plant-Diversity Input Availability. Low polyphenol density in the diet may further strain pool availability, repetitive ultra-processed food patterns with narrow botanical exposure, lack of herbs, spices, legumes, and whole grains, while ecological monotony reducing microbial redundancy.
These pressures may impair BRS5-FM2-PM4 — Microbial Ecological Turnover & Competitive Selection, weaken BRS5-FM2-PM5 — SCFA Production & Signalling, and reduce the effectiveness of BRS5-FM2-PM6 — Polyphenol Biotransformation & Mitochondrial-Relevant Metabolite Generation. At the FM level, this may shift BRS5(FM2) toward reduced microbial metabolite signalling capacity performance.
4.4 Evidence Highlights
Introduction/Summary
The studies below support microbial metabolite signalling capacity as an integrated FM state emerging from coordinated child PM biology — mechanism-qualifying findings that refine framework interpretation, not phenome/outcome science (which belongs in §3).
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Gut-microbiota-targeted dietary interventions modulated human immune status and microbial ecology in controlled feeding contexts — supporting plant-diversity and fermentable-substrate patterns as levers for continuous ecosystem shaping [Wastyk et al., 2021].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Increasing taxonomic diversity expands the ecological possibilities for producing beneficial microbial metabolites and reducing harmful by-products — through ecological competition and turnover among microbial communities [Schleupner and Carmichael, 2022].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Short-chain fatty acids from gut microbial fermentation act as signalling molecules influencing barrier integrity, immune tone, and gut–brain communication — linking microbial fermentation to barrier, immune, and gut–brain signalling [Silva et al., 2020].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Propionate shows protective effects upon the blood–brain barrier in mechanistic framing, linking microbial propionate output to gut-derived signalling relevant beyond local intestinal biology [Hoyles et al., 2018].
- Key References:
5. Connected Mechanisms
- BRS3-FM1-PM2 - Gut-Derived Inflammatory Signalling — biological connection relevant to this mechanism
- BRS4-FM1-PM1 - Electron Transport Chain Function — biological connection relevant to this mechanism
- BRS6-FM2-PM5 - Circadian Feeding & Light-Dark Entrainment — circadian Feeding & Light-Dark Entrainment
6. References
- Wastyk et al. (2021) — Gut-microbiota-targeted Diets Modulate Human Immune Status
- Andreux et al. (2019) — Mitophagy Activator Urolithin a Is Safe and Induces a Molecular Signature
- Singh et al. (2022) — Direct Supplementation with Urolithin a Overcomes Limitations of Dietary Exposure and Gut
- Steckler et al. (2024) — Dysbiosis and Decreased Short-chain Fatty Acids
- Prehn-Kristensen et al. (2018) — Reduced Microbiome Alpha Diversity in Young Patients with ADHD
- Schleupner and Carmichael (2022) — Closing Research Gaps Through Female Inclusion in Study Design